Resverlogix Competitors and Similar CompaniesClear all

CRISPR Therapeutics's competitors and similar companies include Lexicon Pharmaceuticals.
CRISPR Therapeutics
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Founding Date
Founding Date
2013
Founding Date
1995
Type
Type
Public
Type
Public
Tags
Locations
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
San Francisco, US
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Bernards, US
Birmingham, US
Boston, US
Charlotte, US
see more
Employees
Employees
393
Employees
20216% increase
Valuation ($)
Valuation ($)
4.2 b
Valuation ($)
737.4 m

Financial

Revenue (est.)
Revenue (est.)
$3.5m (FY, 2025)
Revenue (est.)
$49.8m (FY, 2025)
Net income
Net income
($581.6m) (FY, 2025)
Net income
($50.3m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 127m
Total funding raised
$ 244.7m
For sources of this data, please see the company profile

View Company Profiles

Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company